Steroids and Pain Control After Tonsillectomy
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Jun 20, 2019
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether giving children a single dose of steroids after they have their tonsils removed (a surgery called tonsillectomy) can help reduce pain and lessen the need for stronger pain medications, like narcotics. The researchers want to see if steroids can make recovery easier for kids who are having this common surgery, which is often done to treat problems like frequent throat infections or sleep issues.
To participate in this study, children need to be between 3 and 12 years old and scheduled for outpatient tonsillectomy, meaning they will go home the same day of the surgery. However, some children won't be eligible, such as those with bleeding disorders, recent use of steroids or strong pain medications, or if there were complications during the surgery. Families who participate will be contacted after the surgery to check on the child's recovery and pain levels. This trial is currently looking for participants, and it's a great opportunity to help improve pain management for kids after tonsillectomy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 3-12
- • Tonsillectomy with or without adenoidectomy for any indication
- • Outpatient (same day) surgery
- Exclusion Criteria:
- • Bleeding disorder
- • Intra-operative surgical or anesthetic complication or unplanned admission
- • Pre-operative steroid use (defined as any steroid use greater than three days duration within 30 days prior to tonsillectomy)
- • Pre-operative opioid use (defined as any opioid use within 30 days prior to tonsillectomy)
- • Inability of parent/guardian to be contacted by phone for follow up
- • Inability or unwillingness of subject or legal guardian/representative to give informed consent
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Trial Officials
Phayvanh Pecha, MD
Principal Investigator
Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials